Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development

20Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides.

Cite

CITATION STYLE

APA

Jacob, B., Vogelaar, A., Cadenas, E., & Camarero, J. A. (2022, October 1). Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development. Molecules. MDPI. https://doi.org/10.3390/molecules27196430

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free